House of Commons Hansard #315 of the 44th Parliament, 1st Session. (The original version is on Parliament's site.) The word of the day was pharmacare.

Topics

(Return tabled)

Question No.2489—Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Conservative

Adam Chambers Conservative Simcoe North, ON

With regard to phone lines paid for by the government, broken down by cellular line versus traditional landline, for each part of the question: (a) how many phone lines was the government paying for as of April 1, 2024; (b) how many of the phone lines are dormant; (c) how many of the phone lines are active but have not been used or have not had any activity in the last year; (d) how many of the phone lines are considered redundant; and (e) what was the total amount spent on phone lines during the 2023 calendar year or the 2023-24 fiscal year, if known, broken down by service provider?

(Return tabled)

Question No.2492—Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Conservative

Todd Doherty Conservative Cariboo—Prince George, BC

With regard to federal procurement: (a) how many cases of suspected invoicing fraud by Information Technology (IT) subcontractors have been submitted to the RCMP for investigation since January 2024; and (b) which departments are involved?

(Return tabled)

Question No.2493—Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Conservative

Todd Doherty Conservative Cariboo—Prince George, BC

With regard to revoked or suspended security clearances of contractors since January 2024: what are the details of all revoked contracts, including the (i) department, (ii) vendor, (iii) value, (iv) description of the goods and services, (v) date the contract was signed, (vi) start and end dates?

(Return tabled)

Question No.2494—Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Conservative

Todd Doherty Conservative Cariboo—Prince George, BC

With regard to contracts awarded through a non-competitive process since March 2020: what is the total value of contracts awarded to (i) GC Strategies, (ii) Dalian Enterprises Inc., (iii) Amazon Web Services Inc., (iv) Microsoft Canada Inc., (v) TEKsystems Inc., (vi) Donna Cona Inc., (vii) MGIS Inc., (viii) 49 Solutions, (ix) Makwa Resourcing Inc., (x) TPG Technology Consulting Ltd., (xi) Advanced Chippewa Technologies Inc.?

(Return tabled)

Question No.2495—Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Bloc

Maxime Blanchette-Joncas Bloc Rimouski-Neigette—Témiscouata—Les Basques, QC

With regard to federal spending in the electoral district of Rimouski-Neigette—Témiscouata—Les Basques, broken down by fiscal year since 2018–19, inclusively: (a) what is the total amount for each fiscal year; (b) what is the detailed breakdown of the amounts in (a) by department, Crown corporation, agency or organization; and (c) what grants and contributions were made, broken down by funding source?

(Return tabled)

Question No.2496—Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Conservative

Arnold Viersen Conservative Peace River—Westlock, AB

With regard to Transport Canada (TC) and the Canadian Transportation Agency data for air travel from January 1, 2018, to December 31, 2023: (a) how many in-flight medical events occurred in Canadian airspace; (b) what is the breakdown of (a) by (i) flight type (i.e. commercial, private, freight, charter, other), (ii) airline, (iii) affected person type (i.e. pilots, other flight crew and passengers), (iv) year, (v) month; (c) how many in-flight medical events occurred on airplanes registered in Canada outside the Canadian airspace; (d) what is the breakdown of (c) by (i) flight type (i.e. commercial, private, freight, charter, other), (ii) airline, (iii) affected person type (i.e. pilots, other flight crew and passengers); (e) how many flights and miles were flown in Canadian airspace; (f) how many emergency landings occurred in the Canadian airspace; (g) what is the breakdown of (f) by (i) reason, (ii) airline, (iii) airplane model; (h) how many active Canadian commercial pilots, flight attendants, and air traffic controllers died; (i) what medical screening changes occurred with respect to pilots, flight attendants, and air traffic controllers (e.g. medical certification requirements changes); (j) for each medical screening change, (i) what it the reason, (ii) what is the date of the change, (iii) who are the persons and decision bodies who approved the change; (k) how many pilots, flight attendants, and air traffic controllers claimed disability; (l) how many pilots, flight attendants, and air traffic controllers applied for medical leave; (m) how many pilots underwent their annual medical examination; (n) how many pilots failed their annual medical examinations; (o) how many active pilot licenses existed; (p) how many pilots, flight attendants, and air traffic controllers lost their employment or were placed on an unpaid leave as a result of refusal to take the COVID-19 vaccines or refusal to inform their employer about their COVID-19 vaccination status; (q) how many pilots lost their license for medical reasons; (r) does TC keep data relating to the numbers of Category 1-3 medical certificates that are (i) held, (ii) temporarily suspended, (iii) permanently suspended for non-compliance with COVID-19 vaccine policy; and (s) if the answers to (r)(i), (r)(ii) or (r)(iii) are affirmative, what is the data?

(Return tabled)

Question No.2501—Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Conservative

Greg McLean Conservative Calgary Centre, AB

With regard to government funding of non-governmental organizations or groups, from November 4, 2015, to present: (a) how much money has the government allocated to (i) Green Economy Canada, (ii) Alberta EcoTrust, (iii) Corporate Knights, (iv) Echo Foundation, (v) Eco Canada, (vi) Ivey Foundation, (vii) Resilient LLP, (viii) Canadian Climate Institute, (ix) Ecofiscal Commission; (b) for each entity in (a), what are the details, including the (i) department, agency or other government entity, (ii) date of the funding, (iii) amount and deliverables expected; (c) of the allocations in (a), which ones were (i) sole-sourced, (ii) awarded through a competitive bidding process; (d) of the allocations in (c)(ii), what was the (i) duration of the competition, (ii) number of organizations that submitted bids for the required deliverables; and (e) what programs from each organization in (a) received government funding, broken down by year and deliverables expected?

(Return tabled)

Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Liberal

Kevin Lamoureux Liberal Winnipeg North, MB

Madam Speaker, I ask that the remaining questions be allowed to stand, and then I think we go to notice of motions after that.

Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Liberal

The Assistant Deputy Speaker (Mrs. Alexandra Mendès) Liberal Alexandra Mendes

Is that agreed?

Questions Passed as Orders for ReturnsRoutine Proceedings

5:35 p.m.

Some hon. members

Agreed.

Motions for PapersRoutine Proceedings

5:35 p.m.

Winnipeg North Manitoba

Liberal

Kevin Lamoureux LiberalParliamentary Secretary to the Leader of the Government in the House of Commons

Madam Speaker, I would ask that all notices of motions for the production of papers also be allowed to stand.

Motions for PapersRoutine Proceedings

5:35 p.m.

Liberal

The Assistant Deputy Speaker (Mrs. Alexandra Mendès) Liberal Alexandra Mendes

Is that agreed?

Motions for PapersRoutine Proceedings

5:35 p.m.

Some hon. members

Agreed.

The House resumed from April 29 consideration of the motion that Bill C‑368, An Act to amend the Food and Drugs Act (natural health products), be read the second time and referred to a committee.

Food and Drugs ActPrivate Members' Business

May 22nd, 2024 / 5:35 p.m.

Bloc

Caroline Desbiens Bloc Beauport—Côte-de-Beaupré—Île d’Orléans—Charlevoix, QC

Madam Speaker, this bill amends the Food and Drugs Act to provide that natural health products are not therapeutic products within the meaning of the act and are therefore not subject to the same monitoring regime as other drugs.

First of all, I would like to announce that the Bloc Québécois will vote in favour of the bill at second reading, essentially to hear from experts in committee on the best way to regulate natural health products.

This bill follows what the government surreptitiously introduced in a schedule to the 2023 budget, through Bill C‑47. There has always been a distinction between drugs and natural health products, and that was a good thing. It seems obvious that natural health products, commonly abbreviated as NHPs, differ from drugs in many ways. We are not saying that they are all harmless; people should ask their pharmacist before consuming any such products. We also acknowledge that NHPs could interact with other medications. However, these are precisely the reasons why we need to examine these products and determine the best way to regulate them.

What the Bloc Québécois wants is to be able to verify whether the decision to subject NHPs to the Protecting Canadians from Unsafe Drugs Act, or Vanessa's Law, is definitely the best way to regulate them, or whether it places an excessive administrative burden on these products. Relatively speaking, these products present lower risks and have a different impact on health than traditional pharmaceuticals.

As the saying goes, sometimes the cure is worse than the disease. Regulations could have the opposite effect to what we are trying to achieve, which is the well-being of Quebeckers and Canadians. The fact is that there are some 91,000 NHPs, 75 of which have been specifically analyzed. After checking certain sampled products, it was concluded that, since 2014, Health Canada has not been doing its job in terms of guaranteeing safe products. The government tried to gain credibility by using a bazooka to kill a fly. That is a reasonable conclusion.

The decision to subject NHPs to Vanessa's Law follows a series of recommendations set out in a report by the commissioner of the environment and sustainable development. In that report to the Parliament of Canada, the commissioner notes that the government does not have the legislative authority to compel NHP companies to identify unlicensed products and take appropriate measures to prevent them from being sold in Canada; identify unauthorized activities and take appropriate action to ensure that product labels and advertisements meet product-licence conditions; obtain the information it needs to verify and ensure that these products are no longer for sale in Canada; and force a recall or impose terms and conditions to mitigate the safety risks associated with these products.

Canada's natural health products regulations allow for licences to be cancelled to prohibit the sale of a product or to have it seized. However, there is no provision allowing the minister to force a product recall. Prior to Bill C‑47, recalls were therefore voluntary. Moreover, the environmental risks are not included, so there is some data missing.

As legislators, have we done everything we can to ensure that there is a balance in terms of access to NHPs to guarantee free choice for consumers? Have we done everything we can to ensure that when Health Canada approves products, it does its job and does the necessary inspections?

One of my colleagues, the member for Montcalm and Bloc Québécois health critic, asked whether an impact study had been done on the industry and on small and medium-sized businesses, concerning the recovery costs required. He was told that it was based on Treasury Board guidelines.

I imagine that the Treasury Board's main interest is getting its money's worth. What kind of service is it going to provide when, after all this time, and with all the taxes generated by the industry, it has not even been able to ensure products are tested or inspected throughout its mandate? These are questions that need to be asked. Where are the numbers on how many adverse reactions there have been to natural health products in 17 years? What are the numbers for adverse reactions to pharmaceutical products? We did not get an answer on that either. We know that even though they are approved by Health Canada, pharmaceuticals can sometimes have very serious side effects. However, that is no reason to disqualify them or discredit an entire industry.

It is just a matter of doing the work, carrying out tasks and responsibilities and making sure that things are done well. That seems obvious to me.

What we see here looks like a government uninterested in working to ensure the well-being of its people. Instead, it wants to pass on a hot potato before it gets burned. For a long time now, the government's inaction on many issues has been on full display. It does not know how to work the machinery of government, so a one-size-fits-all solution often seems like the easiest way around the problem. In reality, it is a very poor option.

We have to respect people's intelligence. To properly protect them, they need to be adequately informed. They do not need to have decisions constantly made for them. No one is forced to use an NHP. Consumers who buy these products have already looked into their effects. The role of legislation and regulations is to provide them with a proper framework.

My grandfather used balsam fir gum. He used it for a good part of his life and died at the age of 103. Was this natural health product approved? Probably not. Was it dangerous? Obviously not. He lived for over 100 years. It was not a dangerous drug either. To some extent, if we let the government have its way, balsam fir gum will probably fall out of use, and my grandfather would have been deprived of his traditional remedy, which had supposedly cured him of consumption. One day, after years of searching, he found it again on the shelves at his pharmacy, in capsule form. The midwife who had supplied it to him back in the day had died. This is why NHPs deserve a legal, responsible, credible and rigorous approach. People should be able to opt for a safe, natural solution with components that are recognized and identified, and whose effects are known and accessible to all doctors and practitioners.

Here, we vote on laws. We are not experts, but we need to act responsibly and with humility to put in place the proper legislative provisions. That is what must guide our decisions. That is why Bill C‑368 is now necessary. It must be sent to committee so that the parliamentary work can be done. If the government had been a bit more transparent, if it had held the necessary consultations, if we had all worked together to find a way to move forward without harming an industry that Quebeckers and Canadians have the right to access, then we would not be here today discussing this issue.

Unfortunately, the government has not held any consultations to date. The federal government has rather cavalierly dodged many debates on this topic, when the purpose of debate is to turn ambiguous questions into clearer, more appropriate directives. That is exactly why we are going to vote in favour of Bill C‑368.

The information I shared in my speech provides ample justification for Parliament to refer this bill to committee. A genuine assessment of the situation is needed given the government's claim that 88% of the 91,000 natural health products are substandard or use misleading labelling. Such a claim requires verification, since the methodology used is flawed. Indeed, the products were verified after problems were reported, and were then identified as substandard. However, this approach grossly inflates the data and raises reasonable questions concerning the methodology used. In our opinion, a randomized approach would be preferable.

Need I remind the House that we have the right to do substantive work to ensure that we are making the right decisions, voting for the right things and passing legislation in the public interest? Need I remind the House that we cannot be sloppy or try to get rid of things or hide the flaws that we did not bother to tackle, things that were swept under the rug because it is easier that way and makes us look good? It is a fairly common technique used by the current government to jump to hasty and ill-considered conclusions, only to impose drastic, rigid rules, where there are often more losers than winners in the end. The Liberals just want to be able to say that they did this, that and the other thing, that they passed this bill and that bill, and they are great. They want to say that they delivered. There was a problem with NHPs, and they passed legislation. It is not enough, but that does not matter. Fisheries are being closed. The government is not listening to those who work in fisheries. Entire villages are facing a socio-economic dead end. It does not matter, as long as the Liberals look good. They say they are going to save the biomass, but they are not saving anything. It does not matter, because announcements have been made. They pass laws and set up legislative procedures to interfere in provincial jurisdictions. It is full steam ahead. Are their solutions correct? Are they being applied consistently? No, but that does not matter.

What matters is that they passed legislation, that they spread their tentacles where they did not belong. That is the way to gain control of everything. They announce funding that is appealing to the provinces that have become so strapped for cash over the years—

Food and Drugs ActPrivate Members' Business

5:45 p.m.

Liberal

The Assistant Deputy Speaker (Mrs. Alexandra Mendès) Liberal Alexandra Mendes

I am sorry to interrupt the hon. member, but she is well over her time.

Resuming debate.

The hon. member for Cowichan—Malahat—Langford.

Food and Drugs ActPrivate Members' Business

5:45 p.m.

NDP

Alistair MacGregor NDP Cowichan—Malahat—Langford, BC

Madam Speaker, I am very pleased to speak to Bill C-368. I would like to thank the member for Red Deer—Lacombe for bringing it forward for the House's consideration.

The reason I am very pleased is that the issue of natural health products has garnered a lot of attention in my riding of Cowichan—Malahat—Langford. I have had a lot of constituents and local businesses approach me concerning this issue in particular. I am pleased to be able to stand here, as their elected representative, and let my constituents know that I will be supporting the bill at second reading.

I was also very pleased to be able to add my name as a joint seconder to the bill. To fulfill the wishes of my constituents, I will be voting to send it to committee for further study.

What are we talking about when we say “natural health products”? I have always thought it a weird thing that they are regulated under a statute such as the Food and Drugs Act. They are not really a food, nor are they a drug. They occupy a special place for many people. We must face that humans have had relationships with natural health products dating back thousands of years. Many of these products have a very special place in human history, and a lot of cultures have very long relationships with them.

Today, in the modern world, natural health products often come in a variety of forms, such as tablets, capsules, tinctures, solutions, creams, ointments and drops. There is quite a large variety for people to pick and choose from. They are often made from plants, but they can also come from animals, from micro-organisms and from marine sources. They include vitamins and minerals, herbal remedies, homeopathic medicines, traditional medicines, probiotics and other products, such as amino acids and essential fatty acids. They are found in many everyday consumer products.

Let us come to the bill in question, Bill C-368. As shown in the summary, it would amend the Food and Drugs Act to provide that natural health products are not therapeutic products within the meaning of that act and, therefore, are not subject to the same monitoring regime as other drugs.

Before we get into the substance, we need to take a little history lesson on how we arrived here. I want to say that both Conservatives and Liberals have run into trouble when trying to regulate natural health products. In fact, the previous government, under Harper, learned this lesson very quickly back in 2008 when it introduced Bill C-51. That was also an act to amend the Food and Drugs Act. Under Bill C-51, the term “therapeutic products” encompassed a range of products sold for therapeutic purposes, including drugs, medical devices, biologics and natural health products. In the end, because of an election, that bill was never adopted. However, I believe the Harper government at that time learned its lesson because of the uproar that came in response to Bill C-51, and it did not attempt to change Canada's regulations for natural health products again while in government.

What the Harper government did do, in 2014, was introduce Bill C-17 to amend the Food and Drugs Act. It was also known as Vanessa's Law. This introduced a definition for the term “therapeutic product”, but what was different this time was that the definition was worded in such a way that it did not include natural health products, within the meaning of the natural health products regulations.

We then fast-forward to the present Liberal government and Bill C-47. That bill, in a clause buried deep within a budget implementation act, again amended the term “therapeutic product” to make sure that the exemption from the natural health products regulations was actually removed. This has caused much of the uproar we see today.

I want to point out, as I said in my intro, that natural health products have a long history of use in Canada as low-risk, affordable methods of promoting well-being. It is very important that I stand here today and say unequivocally that they must remain accessible to all Canadians. I am proud to be a member of a caucus, the NDP caucus, that has long supported an appropriate regulatory category for natural health products to certify their safety and efficacy based on sound evidence, as well as to ensure that they are widely available for those who use and value them.

It is unacceptable that the changes to the regulatory regime under the Food and Drugs Act was snuck into a budget omnibus bill, because it did not allow for proper study. I am glad to see that, because Bill C-368 is a stand-alone, quite simple and easy-to-read piece of legislation, from reading the room, it should have enough votes to send it to committee. We can then have the proper study; hear from Canadians and businesses that sell natural health products, the practitioners involved in this every day; and, finally, get the proper scrutiny that this issue so richly deserves.

I do not want to spend too much longer speaking to the bill, but I want to talk a bit about the people in my riding of Cowichan—Malahat—Langford who took the time to write to my office, phone me personally and come into my office. In particular, I want to recognize a few of the local businesses. Essential Remedies, Benoit and Associates Health Education, some holistic health practitioners, the Community Farm Store, Botanical Bliss, a certified homeopathic practitioner, a naturopathic physician and Lynn's Vitamin Gallery all took the time in the summer of 2023 to come into my office. We had a great round table discussion. It lasted well over an hour. It was really enlightening for me, as their member of Parliament, to hear their views on this subject and learn a little more about why it is so important.

Yes, my immediate family definitely uses natural health products, and I know that many friends and relatives in my immediate vicinity also use them. However, to hear from professionals who work with clients every day about why this issue is so important was particularly enlightening for me. It is also important to note that 71% of Canadians, which is a very big number, have used natural health products, such as vitamins and minerals, herbal products and homeopathic medicines. Therefore, it is important that, when the NHP community speaks to their elected representatives, it represents a very clear majority of Canadians. Based on a proper cross-sampling of the correspondence that I, like many other members, have received, I know that they want their elected representatives to treat this issue with the seriousness that it deserves and give the bill full scrutiny.

Finally, I want to congratulate the NHP community and industry, which have been very actively engaged on this issue through their work. I really want to single out the local businesses in my riding of Cowichan—Malahat—Langford and the constituents who live on Vancouver Island. I congratulate them for their advocacy, for stepping up to the plate and for engaging me as their elected representative, because it has worked. I am proud to say that, in this place, as their elected representative, I will be pleased to vote to send Bill C-368 to committee.